What is Sonova H Ag (SOON.SW)?
Sonova H Ag trades as SOON.SW on the SW exchange (Switzerland) in the Closelooknet research universe, as of the registry build of 2026-11-07.
Is SOON.SW in a Closelooknet index?
Yes — Sonova H Ag is a constituent of HALO Growth 100, as of 2026-11-07.
Where does SOON.SW trade against its moving averages?
Sonova H Ag trades 14.5% above its 50-day and 36.4% above its 200-day moving average (4.7% above its 20-day). As of 2026-11-05 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.
How is SOON.SW doing against its Closelooknet index?
Over the past month Sonova H Ag is +12.8% against +1.3% for the HALO Growth 100 — 11.5 points ahead of its index, as of 2026-11-06. Its Surgical, Med Devices & Animal Health sleeve is +13.6% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.
How does Sonova H Ag compare with its peers?
Against its peer group (HALO Growth 100 · Surgical, Med Devices & Animal Health), Sonova H Ag (SOON.SW) sits 0.5% below its 52-week high, 14.5% above its 50-day average; DexCom Inc (DXCM) is 8.8% below, Globus Medical (GMED) is 19.7% below, IDEXX Laboratories Inc (IDXX) is 12.9% below, as of 2026-11-05. Put any of them next to SOON.SW in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.
What does Sonova H Ag do?
Sonova designs, makes and sells hearing devices and related services, running through Hearing Instruments, Cochlear Implants and Lifestyle-Aligned segments. The Hearing Instruments arm covers Phonak, Unitron, Hansaton and Sennheiser branded aids and headsets plus audiological clinics under several retail names. The Cochlear Implants unit builds implantable hearing systems under the Advanced Bionics brand, and the Lifestyle-Aligned segment adds connected, AI-linked features to its devices. Its peer group covers surgical, med-device and animal-health names such as Intuitive Surgical, Stryker, IDEXX Laboratories, DexCom, Insulet, Globus Medical and Sartorius, grouped for their regulated moats and long compounding histories; the market also names Cochlear as a direct competitor in implants. (Company snapshot of 2026-09-17.)
Where does Sonova H Ag sit in the AI build-out?
Sonova sits in our HALO Growth 100, the growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve that groups regulated device makers built for steady, long-run demand. It carries no seat in Rubin, our AI build-out index; inside the healthcare sleeve it is a maker of devices that now embed AI features rather than a supplier into the chip or data-centre stack. Sonova holds a seat in the HALO Growth 100 and carries a Closelooknet score, with momentum the strongest of its seven modules and valuation the weakest; the diary has not logged a quote or mention for it yet. (Company snapshot of 2026-09-17.)
Does Sonova H Ag pay a dividend?
Sonova H Ag has paid 4.70 CHF per share over the last twelve months, paid once a year, a trailing yield of 1.63% on the 2026-11-06 close; the last distribution recorded in the price series was 4.70 CHF on 2026-06-19. In fiscal 2026 the company paid 262 m CHF in dividends and bought back 63 m CHF of its own shares, 54% of that year’s free cash flow. The share count rose 1.3% over the fiscal year. As of 2026-11-06; the "Dividends and capital return" block on this page carries the lines.
What does this page show?
A live price chart with SMA overlays and drawing tools for SOON.SW, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.